BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Scientists in Moscow have successfully developed Russia’s first lumbar spine phantom. This model will enable ...

The sacral chakra also known as Svadhisthana in Sanskrit is the second of the seven primary chakras Positioned just below the navel this energy center is closely linked to emotions creativity and sens ...

Professor Park Joon-ho's team of plastic surgery surgery at Boramae Hospital in Seoul Metropolitan Government, operated by ...

The seven chakras, energy centers along the spine, can become blocked, impacting well-being. Each chakra governs specific ...

Axonics Modulation Technologies ( (AXNX) ) has released its Q3 earnings. Here is a breakdown of the information Axonics Modulation Technologies ...

Oklahoma City Repertory Theater is staging the regional premiere of Larissa FastHorse's hit holiday comedy Nov. 7-17.

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

“Sacral and Implantable Tibial Neuromodulation for the Management of Overactive Bladder: A Systematic Review and Meta-analysis” highlights the efficacy and safety of iTNM for treating UUI and ...

MANILA, Philippines — University of the East Ramon Magsaysay (UERM) Medical Center an institution for medical education and healthcare delivery, performed the country’s first endoscopic sacral ...